WBC
GILD icon

West Branch Capital’s Gilead Sciences GILD Stock Holding History

West Branch Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
2,186
+3
+0.1% +$395 0.06% 70
2026
Q1 		$304K Buy
2,183
+3
+0.1% +$420 0.08% 67
2025
Q4 		$268K Buy
2,180
+4
+0.2% +$486 0.07% 73
2025
Q3 		$242K Buy
2,176
+3
+0.1% +$341 0.06% 81
2025
Q2 		$241K Sell
2,173
-1,940
-47% -$206K 0.07% 79
2025
Q1 		$461K Sell
4,113
-855
-17% -$88.2K 0.15% 55
2024
Q4 		$459K Sell
4,968
-2,184
-31% -$197K 0.15% 57
2024
Q3 		$600K Sell
7,152
-435
-6% -$33.2K 0.21% 53
2024
Q2 		$521K Sell
7,587
-3,221
-30% -$215K 0.19% 54
2024
Q1 		$792K Buy
10,808
+9,929
+1,130% +$764K 0.32% 44
2023
Q4 		$71.2K Hold
879
– – 0.03% 138
2023
Q3 		$65.9K Sell
879
-151
-15% -$11.6K 0.03% 138
2023
Q2 		$79.4K Buy
1,030
+1
+0.1% +$80 0.04% 128
2023
Q1 		$85.3K Sell
1,029
-123
-11% -$10.2K 0.05% 123
2022
Q4 		$98.9K Buy
1,152
+1
+0.1% +$79 0.06% 121
2022
Q3 		$71K Buy
1,151
+2
+0.2% +$126 0.04% 142
2022
Q2 		$71K Buy
1,149
+1
+0.1% +$62 0.04% 147
2022
Q1 		$68K Sell
1,148
-192
-14% -$12.3K 0.03% 165
2021
Q4 		$97K Sell
1,340
-48
-3% -$3.31K 0.04% 146
2021
Q3 		$97K Buy
1,388
+1
+0.1% +$70 0.05% 137
2021
Q2 		$96K Buy
+1,387
New +$92.6K 0.05% 142
2020
Q2 		– Sell
-3,838
Closed -$287K – 86
2020
Q1 		$287K Sell
3,838
-2,732
-42% -$189K 0.27% 58
2019
Q4 		$427K Sell
6,570
-12,157
-65% -$792K 0.3% 67
2019
Q3 		$1.19M Buy
+18,727
New +$1.22M 0.88% 41

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

West Branch Capital's GILD Position: Q2 2026 in Review

West Branch Capital increased its Gilead Sciences (GILD) stake by 0.14% in Q2 2026, buying an estimated $395 and bringing the position to 2,186 shares worth $276K. The position accounts for 0.06% of the portfolio, ranked #70.

West Branch Capital first reported a position in GILD in Q3 2019 and has held it in 24 quarters since. The position peaked at $1.19M in Q3 2019. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • West Branch Capital held 2,186 shares of Gilead Sciences worth $276K as of Q2 2026.
  • West Branch Capital bought 3 Gilead Sciences shares in Q2 2026, an estimated $395.
  • Gilead Sciences made up 0.06% of West Branch Capital's portfolio in Q2 2026, its #70 holding.
  • West Branch Capital first reported a position in Gilead Sciences in Q3 2019 and has held it in 24 quarters since.
  • West Branch Capital's Gilead Sciences position peaked at $1.19M in Q3 2019.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.